about
Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplicationAntifungal therapy in infants and children with proven, probable or suspected invasive fungal infectionsAntifungal therapy in infants and children with proven, probable or suspected invasive fungal infectionsTriclosan Demonstrates Synergic Effect with Amphotericin B and Fluconazole and Induces Apoptosis-Like Cell Death in Cryptococcus neoformansCandida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysisASDCD: antifungal synergistic drug combination databaseSB-224289 Antagonizes the Antifungal Mechanism of the Marine Depsipeptide Papuamide AHigh-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis.Synergistic Activity of Econazole-Nitrate and Chelerythrine against Clinical Isolates of Candida albicansA repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosisPractice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis.Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosisCandida parapsilosis, an emerging fungal pathogenActivities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.Cryptococcus neoformans Yap1 is required for normal fluconazole and oxidative stress resistanceEstrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo.Synthetic organotelluride compounds induce the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisiae.Essential gene discovery in the basidiomycete Cryptococcus neoformans for antifungal drug target prioritizationOptimization of polyene-azole combination therapy against aspergillosis using an in vitro pharmacokinetic-pharmacodynamic model.Exploring the molecular basis of antifungal synergies using genome-wide approaches.Combination of Amphotericin B and Flucytosine against Neurotropic Species of Melanized Fungi Causing Primary Cerebral Phaeohyphomycosis.Synergistic combination of violacein and azoles that leads to enhanced killing of major human pathogenic dermatophytic fungi Trichophyton rubrumIn vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C. parapsilosis.In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis.Posaconazole activity against Candida glabrata after exposure to caspofungin or amphotericin B.In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methodsCandida resistance and its clinical relevance.In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.Combination antifungal therapy: the new frontier.Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.Efflux-mediated antifungal drug resistance.Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity.Combinatorial strategies for combating invasive fungal infections.Antifungal drug development: challenges, unmet clinical needs, and new approaches.Triazole antifungal agents in invasive fungal infections: a comparative review.Combination antifungal therapy for invasive fungal infections in children and adults.Combinatorial drug approaches to tackle Candida albicans biofilms.
P2860
Q21563342-7844D068-0F79-4787-BEDA-9C9093B797F9Q24239978-8C4FFE99-93E9-4210-8489-56354803211AQ24243629-995E8B65-AC7B-41F2-A22C-D50340075CD2Q28390076-BD3AC1BA-E70B-4FA4-911F-AB2CAF86E53AQ28533912-33E0A8A2-F863-4034-B2BA-AF1A1BE455E5Q28539135-3CE4E280-96CC-445D-A8B0-0219940A33C5Q28552091-F938DE17-46B5-4198-A609-2CD773CE7F31Q33875911-9C135632-7FB9-4485-806F-26C11A699A50Q34146130-C1199733-2557-4DC9-B42F-2825627CB1E6Q34513852-16E109A8-842A-4B22-A704-C709F17DD319Q34532546-3B51DF55-FD8B-4013-B3E6-3348FA66F21CQ34540684-378DF26C-0830-41D8-B1FC-3A81776B0976Q34737783-BE01A1E0-BCA6-42FA-857C-C52E112A09E8Q34852747-D35951F5-42EC-4AC7-AB39-7A8842035737Q34932922-208FE14A-53E8-46EA-BA75-44FD0B050F04Q34943653-3AFA5274-7CB3-4BD3-983D-76FFA7007721Q35092521-4A0FBBF7-F610-42AF-B94A-115177C3B9FEQ35213291-7EE746BB-63D9-4391-A940-0B7A5DB9C9D1Q35677545-2546DA43-1784-48A4-A43F-209CB8DC60A6Q35746264-EE445FB8-0525-433F-BFE1-66A1C398E55EQ35854979-C777C965-9990-4162-A3EE-933F96C78888Q35911359-3399DFE8-BA92-411A-A1F6-F99F333303D0Q35935950-1287E4ED-6841-4FC3-9383-08129658F2C5Q36018571-9A4D9FA2-ADA8-4F44-BA1F-B90E8BC82739Q36314153-B519A032-B069-413D-BB67-2972B1A7E1DBQ36396166-3215F1C0-407E-41F6-B322-1DBAA07DF5C0Q36424973-A76FDB53-0972-4751-B3DC-3A21B607CCDEQ36425093-50E6F8B4-C055-444A-9FE2-6EE05CEA686FQ36484954-AA5EBCB1-B5BB-41DA-9753-1F4ED5C2F084Q36558484-259750F5-2F5B-4A38-9DFA-F0C9AFB20A42Q36895652-C3979258-544B-4D61-9A51-0F656540BE34Q37072109-91F2741B-345C-4419-890F-4C09DC38601EQ37075845-C22C0141-828B-4331-82E4-0A6A9474AC6FQ37156645-9F9948D3-3117-421C-99E6-B163C693DCC4Q37684378-4D9F3537-1757-4521-A7A3-6C55C8BD97DAQ37705303-59532D9A-14D2-4777-B26D-8C01738A5BC9Q37717926-C0E9C60C-B001-4A1F-AF32-F1534B1957D3Q37964703-1BD7EC54-8244-46EE-A503-8254772EB62BQ38102782-31329E48-E654-4B6E-AA81-CE77E070E2A7Q38526460-80DC5A79-35DE-4009-90D0-3691ACB48434
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Combination treatment of invasive fungal infections.
@ast
Combination treatment of invasive fungal infections.
@en
type
label
Combination treatment of invasive fungal infections.
@ast
Combination treatment of invasive fungal infections.
@en
prefLabel
Combination treatment of invasive fungal infections.
@ast
Combination treatment of invasive fungal infections.
@en
P2093
P2860
P1476
Combination treatment of invasive fungal infections.
@en
P2093
Christopher A Hitchcock
Daniel J Sheehan
Mahmoud A Ghannoum
Pranab K Mukherjee
P2860
P304
P356
10.1128/CMR.18.1.163-194.2005
P407
P577
2005-01-01T00:00:00Z